Phathom Pharmaceuticals, Inc. (PHAT)
11.38
-0.49
(-4.13%)
USD |
NASDAQ |
May 18, 16:00
Phathom Pharmaceuticals Profit Margin (Quarterly) : -52.09% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 11.55% |
| Ligand Pharmaceuticals, Inc. | -25.80% |
| Axsome Therapeutics, Inc. | -33.76% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.27% |
| Return on Invested Capital | -85.79% |
| Gross Profit Margin (Quarterly) | 79.42% |
| Operating Margin (Quarterly) | -26.55% |
| Return on Net Operating Assets | -231.7% |